|
OSDBU Menu
|
 |
Forecast by Operating Division
NIH
Download Excel Version
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Jeffrey Williams |
| OPDIV Phone: | (301)-435-0340 |
| OPDIV E-mail |
cvldcontracts@mail.nih.gov |
| Sequence Num: | 23 |
| Solicitation Release Qtr: | 1st Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 3) $1,000,001 to $5,000,000 |
| Description: | PUMPKIN: Contractors will develop for infants and young children with congenital and acquired cardiovascular disease a family of viable mechanical circulatory support devices that will bridge patients to heart transplantation or recovery |
| Incumbant (If any): | |
| View Record Separately | NIH 23 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Jeffrey Williams |
| OPDIV Phone: | (301)-435-0340 |
| OPDIV E-mail |
Jeffrey.Williams@nih.gov |
| Sequence Num: | HHS-NIH-00 |
| Solicitation Release Qtr: | 3rd Qtr FY2010 |
| Procurement Method: | To be determined |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 3) $1,000,001 to $5,000,000 |
| Description: | INTERMACS: A national registry of patients receiving mechanical circulatory support device therapy to treat advanced heart failure. The registry will collect demographics, clinical outcomes, care providers and hospitals, device performance, clinical and laboratory data and tissue samples from patients who are receiving approved durable mechanical circulatory support devices for whom discharge from the hospital is feasible |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-00 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Beverly Hall |
| OPDIV Phone: | (919)-541-3301 |
| OPDIV E-mail |
hall15@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0034 |
| Solicitation Release Qtr: | 4th Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Business Services |
| NAICS: | 811219 |
| Estimated Cost Range: | 3) $1,000,001 to $5,000,000 |
| Description: | Preventive Maintenance and Repair of Government-owned Scientific Laboratory Equipment |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0034 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | David Sedgley |
| OPDIV Phone: | (919)-541-4027 |
| OPDIV E-mail |
sedgley@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0045 |
| Solicitation Release Qtr: | 1st Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 5) $10,000,001 and above |
| Description: | Investigative Absorption, Distribution, Metabolism, and Excretion (ADME) Studies of Toxicants in NTP Animal Model Systems. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0045 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Pam McCord-Reynolds |
| OPDIV Phone: | (301)-435-0337 |
| OPDIV E-mail |
pm359d@nih.gov |
| Sequence Num: | HHS-NIH-0055 |
| Solicitation Release Qtr: | 4th Qtr FY2010 |
| Procurement Method: | To be determined |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 3) $1,000,001 to $5,000,000 |
| Description: | Title: Randomized Evaluation of VAD Intervention before Inotropic Therapy (REVIVE-IT)
The objective of this program is to explore the potential benefit of destination therapy using ventricular assist devices (VADs) in advanced heart failure (HF) patients who have significant functional impairment but have not yet developed serious consequences such as malnourishment, end-organ damage, and immobility. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0055 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Alice Sobsey |
| OPDIV Phone: | (301)-435-0340 |
| OPDIV E-mail |
cvldcontracts@mail.nih.gov |
| Sequence Num: | HHS-NIH-0056 |
| Solicitation Release Qtr: | 3rd Qtr FY2010 |
| Procurement Method: | To be determined |
| Procurement Category: | Research & Development |
| NAICS: | 541711 |
| Estimated Cost Range: | 3) $1,000,001 to $5,000,000 |
| Description: | The goal of Programs of Excellence in Nanotechnology (PEN) will be to develop and enhance nanotechnology-based tools and devices and use them to improve the diagnosis and treatment of heart, lung, and blood diseases. PEN contractors will integrate expertise in multiple disciplines (nanotechnology, physiology, clinical studies, molecular biology, genomics, chemistry, physics, bioengineering, computational biology, bioinformatics, and biostatistics) to advance nanotechnology applications in heart, lung, blood diseases. Contractors will develop nanotechnology-based tools and technologies with the long-term goal of applying them to clinical diagnosis and therapeutics for heart, lung, and blood diseases. Each PEN contractor will identify and address three to five projects focused on heart, lung, and/or blood diseases using an interdisciplinary approach. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0056 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Scott Bredow |
| OPDIV Phone: | (301)-435-0333 |
| OPDIV E-mail |
bredowsa@nhlbi.nih.gov |
| Sequence Num: | HHS-NIH-0062 |
| Solicitation Release Qtr: | 4th Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 4) $5,000,001 to $10,000,000 |
| Description: | The National Heart, Lung, and Blood Institute (NHLBI) is planning to support a Science Moving towards Research Translation and Therapy (SMARTT) program for the production and testing of novel therapeutics to treat heart, lung, and blood diseases. The program will fund one Production Facility (PF) for biologics. The PF, as production facilities, will support translational research. The PF will evaluate and prioritize requests for service based on their ability to fulfill the request. The biologic products are primarily intended for clinical use within the United States. Products may be released by the PF for clinical use only under an IND. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0062 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Scott Bredow |
| OPDIV Phone: | (301)-435-0333 |
| OPDIV E-mail |
bredowsa@nhlbi.nih.gov |
| Sequence Num: | HHS-NIH-0063 |
| Solicitation Release Qtr: | 4th Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 4) $5,000,001 to $10,000,000 |
| Description: | The National Heart, Lung, and Blood Institute (NHLBI) is planning to support a Science Moving towards Research Translation and Therapy (SMARTT) program for the production and testing of novel therapeutics to treat heart, lung, and blood diseases. This program will fund one Production Facility (PF) for non-biologics and small molecules. The PF, as a production facility, will support translational research. The PF will evaluate and prioritize requests for service based on their ability to fulfill the request. The non-biologic and small molecule products are primarily intended for clinical use within the United States. Products may be released by the PF for clinical use only under an IND. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0063 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Scott Bredow |
| OPDIV Phone: | (301)-435-0333 |
| OPDIV E-mail |
bredowsa@nhlbi.nih.gov |
| Sequence Num: | HHS-NIH-0064 |
| Solicitation Release Qtr: | 4th Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 4) $5,000,001 to $10,000,000 |
| Description: | The National Heart, Lung, and Blood Institute (NHLBI) is planning to support a Science Moving towards Research Translation and Therapy (SMARTT) program for the production and testing of novel therapeutics to treat heart, lung, and blood diseases. This program will fund one Pharmacology & Toxicology Center (PTC). The PTC will be established to conduct pharmacology and toxicology analyses for potential biologic, non-biologic, and small molecule therapeutics. The PTC will evaluate and prioritize requests for service based on their ability to fulfill the request. The biologic, non-biologic, and small molecule products are primarily intended for clinical use within the United States. Products may be released by the PF for clinical use only under an IND. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0064 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Scott Bredow |
| OPDIV Phone: | (301)-435-0333 |
| OPDIV E-mail |
bredowsa@nhlbi.nih.gov |
| Sequence Num: | HHS-NIH-0065 |
| Solicitation Release Qtr: | 4th Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 4) $5,000,001 to $10,000,000 |
| Description: | The National Heart, Lung, and Blood Institute (NHLBI) is planning to support a Science Moving towards Research Translation and Therapy (SMARTT) program for the production and testing of novel therapeutics to treat heart, lung, and blood diseases. The coordinating center will provide consulting, manufacturing, preclinical study and early phase clinical trial design, administrative, and regulatory expertise. The CC will also be the monitor and coordinator for organizational and regulatory aspects of the SMARTT Program. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0065 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Alex Navas |
| OPDIV Phone: | 301-496-6546 |
| OPDIV E-mail |
anavas@mail.nlm.nih.gov |
| Sequence Num: | HHS-NIH-0067 |
| Solicitation Release Qtr: | 2nd Qtr FY2010 |
| Procurement Method: | To be determined |
| Procurement Category: | IT Services |
| NAICS: | 541990 |
| Estimated Cost Range: | 3) $1,000,001 to $5,000,000 |
| Description: | Acquisitions of special bioethics material, non-journal material in publicly searchable and free database, development and maintenance of website for general public access. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0067 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Juanita Campbell |
| OPDIV Phone: | (919)-541-7893 |
| OPDIV E-mail |
clement1@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0068 |
| Solicitation Release Qtr: | 1st Qtr FY2010 |
| Procurement Method: | To be determined |
| Procurement Category: | Research & Development |
| NAICS: | 541720 |
| Estimated Cost Range: | 2) $500,001 to $1,000,000 |
| Description: | Key Message Development and Dissemination Research: a model using the breast cancer and the environment research program. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0068 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Jennifer Smith |
| OPDIV Phone: | (919)-541-0424 |
| OPDIV E-mail |
smithj3@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0069 |
| Solicitation Release Qtr: | 1st Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 5) $10,000,001 and above |
| Description: | General Toxicity, Carcinogenicity, Reproduction, and Developmental Toxicity Studies for the NTP in Lab Animals. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0069 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Deitra Lunney |
| OPDIV Phone: | (919)-541-0387 |
| OPDIV E-mail |
Lunney@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0070 |
| Solicitation Release Qtr: | 3rd Qtr FY2010 |
| Procurement Method: | Small Business Set-Aside |
| Procurement Category: | Business Services |
| NAICS: | 561210 |
| Estimated Cost Range: | 3) $1,000,001 to $5,000,000 |
| Description: | Glassware and Media Preparation. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0070 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Paula Pier |
| OPDIV Phone: | (919)-541-2616 |
| OPDIV E-mail |
pierp@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0071 |
| Solicitation Release Qtr: | 1st Qtr FY2010 |
| Procurement Method: | GSA |
| Procurement Category: | Business Services |
| NAICS: | 541513 |
| Estimated Cost Range: | 1) $100,000 to $500,000 |
| Description: | Cental Files and Scientific Computing Support - NTP and DIR. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0071 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Don Gula |
| OPDIV Phone: | (919)-541-0423 |
| OPDIV E-mail |
gula@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0072 |
| Solicitation Release Qtr: | 2nd Qtr FY2010 |
| Procurement Method: | GSA |
| Procurement Category: | Business Services |
| NAICS: | 541513 |
| Estimated Cost Range: | 3) $1,000,001 to $5,000,000 |
| Description: | NTP Statistical and Computer Support |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0072 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Juanita Campbell |
| OPDIV Phone: | (919)-541-7893 |
| OPDIV E-mail |
campbellj@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0073 |
| Solicitation Release Qtr: | 1st Qtr FY2010 |
| Procurement Method: | To be determined |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 5) $10,000,001 and above |
| Description: | Statistical Support. This requirement is considered R&D support. The NAICS code will be addressed after the SOW is finalized. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0073 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Wanda Holliday |
| OPDIV Phone: | (919)-541-0943 |
| OPDIV E-mail |
hollida1@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0074 |
| Solicitation Release Qtr: | 1st Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 5) $10,000,001 and above |
| Description: | IT Services. This requirement is considered R&D support. Once the SOW is finalized, the NAICS code will be set. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0074 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | Pat Barbour |
| OPDIV Phone: | (919)-541-7596 |
| OPDIV E-mail |
barbourp@niehs.nih.gov |
| Sequence Num: | HHS-NIH-0075 |
| Solicitation Release Qtr: | 1st Qtr FY2010 |
| Procurement Method: | Full & Open |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 5) $10,000,001 and above |
| Description: | Chemistry Support Services. |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0075 |
|
|
|
| Operating Division: | NIH |
| OPDIV Contact: | LaMeshia Billington |
| OPDIV Phone: | (301)-435-0365 |
| OPDIV E-mail |
billingtonlr@nhlbi.nih.gov |
| Sequence Num: | HHS-NIH-0076 |
| Solicitation Release Qtr: | 4th Qtr FY2010 |
| Procurement Method: | To be determined |
| Procurement Category: | Research & Development |
| NAICS: | 541712 |
| Estimated Cost Range: | 5) $10,000,001 and above |
| Description: | Lung Tissue Research Consortium (LTRC) Program: The overall objective of the LTRC is to enable better management of lung diseases by increasing understanding of the pathogenetic mechanisms of these diseases through studies of human lung tissues. The LTRC facilitates histopathological and molecular research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to researchers within and outside the Consortium. Collections of specimens are linked to extensive individual, clinical, and phenotypic data. This consortium is currently comprised of four Clinical Centers (CCs), a Data Coordinating Center (DCC), a Radiology Center (RC), and a center that serves as the Tissue Repository (TR). |
| Incumbant (If any): | |
| View Record Separately | NIH HHS-NIH-0076 |
|
|
Last Revised: October 1, 2009
|
